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Abstract. 
 
Subcellular localization directed by speciﬁc 
targeting motifs is an emerging theme for regulating 
signal transduction pathways. For cAMP-dependent 
protein kinase (PKA), this is achieved primarily by
its association with A-kinase–anchoring proteins 
(AKAPs). Dual speciﬁcity AKAP1, (D-AKAP1) binds 
to both type I and type II regulatory subunits and has 
two NH
 
2
 
-terminal (N0 and N1) and two COOH-termi-
nal (C1 and C2) splice variants (Huang et al., 1997. 
 
J
 
.
 
 
Biol
 
.
 
 Chem
 
.
 
 
 
272:8057). Here we report that the splice 
variants of D-AKAP1 are expressed in a tissue-speciﬁc 
manner with the NH
 
2
 
-terminal motifs serving as 
switches to localize D-AKAP1 at different sites. North-
ern blots showed that the N1 splice is expressed prima-
rily in liver, while the C1 splice is predominant in testis. 
The C2 splice shows a general expression pattern. Mi-
croinjecting expression constructs of D-AKAP1(N0) 
epitope-tagged at either the NH
 
2
 
 or the COOH termi-
nus showed their localization to the mitochondria 
based on immunocytochemistry. Deletion of N0(1-30) 
abolished mitochondrial targeting while N0(1-30)-GFP 
localized to mitochondria. Residues 1–30 of N0 are 
therefore necessary and sufﬁcient for mitochondria
targeting. Addition of the 33 residues of N1 targets
D-AKAP1 to the ER and residues 1–63 fused to GFP 
are necessary and sufﬁcient for ER targeting. Residues 
14–33 of N1 are especially important for targeting to 
ER; however, residues 1–33 alone fused to GFP gave a 
diffuse distribution. N1(14-33) thus serves two func-
tions: (a) it suppresses the mitochondrial-targeting mo-
tif located within residues 1–30 of N0 and (b) it exposes 
an ER-targeting motif that is at least partially con-
tained within the N0(1-30) motif. This represents the 
ﬁrst example of a differentially targeted AKAP and 
adds an additional level of complexity to the PKA sig-
naling network.
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cAMP is an important second messenger that regulates
multiple cellular processes by activating cAMP-dependent
protein kinase (PKA)
 
1
 
. PKA exists as a holoenzyme con-
sisting of a regulatory (R) subunit dimer and two catalytic
(C) subunits. cAMP binding cooperatively to the R-sub-
units causes the complex to dissociate, releasing two free
and active C-subunits. Due to the broad substrate specific-
ity of PKA, compartmentalization serves as an additional
regulatory mechanism that can increase both the selectiv-
ity and intensity of a cAMP-mediated hormonal response.
For the free C-subunit, subcellular localization also can be
modulated by PKI which, in addition to serving as an in-
hibitor, also contains a nuclear export signal that actively
exports C from the nucleus (Wen et al., 1995). Localiza-
tion of the inactive holoenzyme, however, is achieved pri-
marily through association with A-kinase–anchoring pro-
teins (AKAPs; Rubin, 1994; Scott and McCartney, 1994;
Pawson and Scott, 1997). AKAPs typically interact with
the NH
 
2
 
-terminal dimerization domain of the type II regu-
latory subunits and are tethered to structural proteins,
membranes, or organelles (Leiser et al., 1986; Hausken
et al., 1994; Lin, 1995; Lester et al., 1996). In some cases
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Abbreviations used in this paper:
 
 AKAP, A-kinase–anchoring protein;
C, cAMP-dependent protein kinase catalytic subunit; D-AKAP1, dual
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dent protein kinase; R, cAMP-dependent protein kinase regulatory sub-
unit; RI, type I regulatory subunit of PKA; RII, type II regulatory subunit
of PKA; SH2, src homology 2. 
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AKAPs, such as AKAP79, act as scaffolds by recognizing
several functionally related enzymes which bind to PKA,
PKC, and protein phosphatase 2B (calcineurin; Coghlan
et al., 1995; Klauck et al., 1996).
A novel AKAP, D-AKAP1, was discovered that can
bind to both type I and type II regulatory subunits (Huang
et al., 1997). Despite its single message in most tissues, sev-
eral D-AKAP1 isoforms or homologues were identified in
various species. These isoforms include mouse S-AKAP84
(Chen et al., 1997), AKAP100 (Chen et al., 1997), and
AKAP121 (Chen et al., 1997); rat AKAP121 (Felici-
ello et al., 1998); human S-AKAP84 (Lin, 1995); and
AKAP149 (Trendelenburg et al., 1996). Mouse homo-
logues of D-AKAP1, as summarized in Fig. 1 A, share a
525–amino acid core, and differ at their COOH termini,
presumably by alternative splicing. This core contains the
R-binding domain that is responsible for interacting with
the regulatory subunit. Therefore, all isoforms should
share the function of anchoring PKA. D-AKAP1a and
mouse S-AKAP84 have relatively short COOH termini,
whereas D-AKAP1c (AKAP121) and AKAP100 both
contain a putative KH domain which was proposed to bind
RNA (Siomi et al., 1993; Trendelenburg et al., 1996; Chen
et al., 1997; Huang et al., 1997)
 
. 
 
The COOH-terminal 19
residues of D-AKAP1a are designated as C1, whereas the
COOH-terminal 333 residues of D-AKAP1c are desig-
nated as C2. In addition to the various COOH-terminal
splices, two NH
 
2
 
-terminal alternative splices, N0 and N1,
were identified in the cloning of D-AKAP1 (see Fig. 1 b).
The N0 splice is included in the 525–amino acid core, and
contains a stretch of hydrophobic residues proposed to be
a mitochondrial-targeting sequence (Lin, 1995; Chen et al.,
1997). The N1 splice contains 33 additional amino acids at
its NH
 
2
 
 terminus, including a potential myristylation site
and a putative PKA phosphorylation site.
Targeting PKA to specific sites in the cell is a major role
of the anchoring proteins. In this study, we choose to fur-
ther investigate this function of D-AKAP1, in particular,
to elucidate the functional importance of the two NH
 
2
 
-ter-
minal splice variants. Using Northern analysis coupled
with immunocytochemistry, we demonstrate that the vari-
ous alternative splice variants are expressed in a tissue-
specific manner and dictate distinctly different subcellular
localizations. Residues 1–30 of N0 are identified to be nec-
essary and sufficient to target D-AKAP1 to the mitochon-
dria while N1 is expressed primarily in the liver, contains
an additional 33 residues and causes D-AKAP1 to localize
to the endoplasmic reticulum (ER).
 
Materials and Methods
 
Materials
 
The following materials were purchased as indicated: Mouse Multiple Tis-
sue Northern Blot (Clontech), Ready-to-Go DNA labeling kit (Phar-
macia), MitoTracker (Molecular Probes), Triton X-100 and guinea pig
IgG (Sigma Chemical Co.), SSC buffer (5
 
9
 
®
 
3
 
9 
 
Inc.), enzymes used for
DNA manipulations (Life Technologies, Inc.), the DNA sequencing kit
(U.S. Biochemical Corp.), monoclonal 12-CA-5 anti-HA tag antibody
(BAbCo), biotinylated donkey anti–mouse IgG antibody, FITC donkey
anti–mouse IgG antibody, donkey anti–rabbit IgG antibody, and Cy-5
conjugated anti–guinea pig IgG antibody (Jackson ImmunoResearch),
Texas red streptavidin (Amersham Corp.), and erythrocyte lysate tran-
scription-and-translation kit (Promega). Antibodies against D-AKAP1
 
were generated in female rabbits at Cocalico Corp. All oligonucleotides
were synthesized at the Peptide and Oligonucleotide Facility at the Uni-
versity of California, San Diego.
 
Northern Analysis
 
Blots containing 2 
 
m
 
g of immobilized mRNAs from selected adult mouse
tissues were probed with 
 
32
 
P-radiolabeled cDNA for the various splice
variants. Nucleotides 1–90 encoding the first 30 residues of D-AKAP1b
were amplified by PCR and used to make the cDNA probe specific for the
N1 splice, nucleotides 2071–2366 of D-AKAP1a were used for the C1
splice, and nucleotides 2953–3317 of D-AKAP1c were used for the C2
splice. Fig. 2 a was taken from Huang et al. (1997), in which nucleotides
854–1226 encoding the kinase binding domain in the core region of
D-AKAP1 were used for a probe common to all the splice variants. Nitro-
cellulose filters were prehybridized in 6
 
3
 
 SSC (750 mM sodium chloride
and 75 mM sodium citrate, pH 7.0), 1% milk, and 0.5 mg/ml salmon sperm
DNA for 4 h at 65°C, then hybridized to 1.5 
 
3
 
 10
 
6
 
 cpm/ml of denatured
radiolabeled cDNA probe in the same buffer. Hybridization was per-
formed at 65°C for 16 h and nonhybridized probe was removed with 0.1
 
3
 
SSC and 0.1%SDS at 65°C. Hybridizing mRNA signals were detected by
autoradiography.
 
Construction of Expression Vectors
 
To determine the subcellular localization of the two NH
 
2
 
-terminal splices
of D-AKAP1, an epitope tag derived from the influenza hemagglutinin
protein (HA) was engineered at either the NH
 
2
 
 terminus or the COOH
terminus for immunofluorescent detection using monoclonal antibodies to
the HA tag (Wilson et al., 1984). To make NH
 
2
 
-terminal HA fusion pro-
teins of N0 and N1, a linker containing the initiation codon of the lu-
ciferase gene and the nine–amino acid HA-tag sequence YPYDVPDYA
was subcloned into the pcDNA3 vector using the BamHI and EcoRI sites.
Another linker was then subcloned into the NotI and XbaI sites down-
stream from the HA tag to make a one nucleotide frameshift at the NotI
site. This new vector was named pcDNA3ML. Finally, cDNAs encoding
D-AKAP1a and D-AKAP1b were subcloned into pcDNA3ML using the
newly engineered NotI site and XhoI. D-AKAP1a and D-AKAP1b both
use the C1 splice but have either N0 or N1, respectively. These two con-
structs, designated as [HA]-N0 and [HA]-N1 for their different NH
 
2
 
-ter-
minal splices, correspond to [HA]-D-AKAP1a and [HA]-D-AKAP1b, re-
spectively. To make COOH-terminal HA fusion proteins of D-AKAP1,
the cDNA encoding the first 144 residues of D-AKAP1a was first excised
from pBS-D-AKAP1a and subcloned into pcDNA3 using EcoRI. A
linker containing the HA tag epitope flanked by a blunt end and a XhoI
restriction site was then ligated in using EcoRV and XhoI. The final con-
struct was designated N0(1-144)-[HA].
To make [HA]-N0(
 
D
 
1
 
-
 
30), which lacks the first 30 amino acids, a NotI
site was engineered at residue 30 of [HA]-N0 by site directed mutagenesis
(Kunkel et al., 1991), and the cDNA encoding residues 1–30 was excised
using NotI. To make deletion mutants of [HA]-N1, a NotI site was engi-
neered at residues Gly13 or Cys24 and cDNAs encoding sequences 1–13
or 1–24 were then excised using NotI. These two constructs lacking the
first 13 or 24 residues of [HA]-N1 were designated N1(
 
D
 
1-13) and N1(
 
D
 
1-
24), respectively.
To make (1-30)N0-[GFP], the first 30 residues of N0 were amplified by
PCR with EcoRI and BglII engineered at the 5
 
9
 
 and 3
 
9
 
 termini and sub-
cloned into vector pEGFP-N1 (Clontech) between EcoRI and BamHI
sites. To make (1-63)N1-[GFP] and (1-33)N1-[GFP],
 
 
 
the first 63 or 33 res-
idues of D-AKAP1b were amplified by PCR with EcoRI and BglII engi-
neered at their 5
 
9
 
 and 3
 
9
 
 termini, respectively. These two fragments were
then subcloned into vector pEGFP-N1 (Clontech) between EcoRI and
BamHI sites.
 
Cell-free Expression of [HA]-N0 and [HA]-N1
 
Expression vectors for [HA]-N0 and [HA]-N1 were tested using an in
vitro transcription-translation kit (TNT T7 Quick coupled system; Pro-
mega). In brief, purified DNA was mixed with rabbit reticulocyte extract
and 10 
 
m
 
Ci [
 
35
 
S]methionine, and incubated at 30
 
8
 
C for 2 h. The assay mix-
tures were separated by SDS-PAGE and visualized by autoradiography
for 48 h. These products were also subjected to immunoblot analysis using
antibodies specific for N0 (anti-RPP7) or N1 (anti-N1), and visualized by
ECL, which takes 
 
,
 
1 min for exposure. 
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Cell Culture and Transient Transfection
 
Mouse 10T1/2 fibroblasts were maintained in DME containing 10% FBS,
and plated at a density of 1 
 
3 
 
10
 
5
 
 cells per 10-cm plate 24 h before trans-
fection. Cells were transiently transfected, using the calcium phosphate
method with 10 
 
m
 
g of DNA per plate (Sambrook et al., 1989). 20 h after
transfection, cells were visualized by fluorescent microscopy either di-
rectly or after fixing with 4% paraformaldehyde.
 
Microinjection Analysis
 
For microinjection, cells were plated on glass coverslips and grown to 70%
confluence in DME 
 
1
 
 10% FBS. The coverslips were then transferred to
DME containing 0.05% calf serum. After 24 h, the cells were injected into
their nuclei with solutions of injection buffer (20 mM Tris, pH 7.2, 2 mM
MgCl
 
2
 
, 0.1 mM EDTA, and 20 mM NaCl) containing 100 
 
m
 
g/ml expres-
sion plasmid DNA. In some experiments, 6 mg/ml guinea pig IgG (Sigma
Chemical Co.) was coinjected as a marker. Experiments were performed
using an automatic micromanipulator (Eppendorf) with glass needles
pulled on a vertical pipette puller (Kopf). For detection of expressed pro-
teins, cells were fixed in 4% paraformaldehyde 5 h after injection for 10
min, and then washed with 0.1% Tween in PBS. The cells were then incu-
bated successively with appropriate antibodies.
 
Cell Staining
 
In general, cells were fixed in 4% paraformaldehyde, permeabilized with
0.3% Triton X-100 in PBS before staining with antibodies. HA-tagged
proteins were stained with primary monoclonal anti-HA tag antibodies
(dilution 1:100) for 1 h at 37°C then incubated with rhodamine-conju-
gated donkey anti–mouse IgG antibodies (dilution 1:200). In some experi-
ments, the secondary antibody is biotinylated donkey anti–mouse IgG,
which is in turn stained by Texas red streptavidin. To stain mitochondria,
two methods were used. 200 nM of a mitochondrion-specific dye (Mi-
totracker; Molecular Probes Inc.) was incubated with the microinjected
cells for 30 min before fixation. Alternatively, a vector encoding a mito-
chondrial-specific green fluorescent protein ([GFP]-mito; Llopis et al.,
1998) was comicroinjected with the HA-tagged proteins, and mitochon-
dria were visualized directly by GFP. In addition, cells were stained with
Cy-5 conjugated anti–guinea pig IgG (dilution 1:100) to discriminate in-
jected from noninjected cells. To stain ER, cells were incubated with rat
anti-Bip antibodies (dilution 1:100), washed three times with 0.1% Tween
in PBS, and probed with fluorescein-conjugated donkey anti–rat IgG (di-
lution 1:100). Between incubations with different antibodies, cells were
washed three times with 0.1% Tween in PBS for 5 min each time at room
temperature to eliminate nonspecific staining.
 
Laser-scanning Confocal Microscopy
 
Samples were visualized by confocal microscopy using an MRC-1024 sys-
tem (Bio Rad Laboratories) attached to an Axiovert 35M (Zeiss AG) and
a 40
 
3
 
 NA objective. Excitation illumination was with 488-, 568-, and 647-
nm light from a krypton/argon laser. Individual images (1024 
 
3
 
 1024 pix-
els) were converted to PICT format and merged as pseudo-color RGB im-
ages using Adobe Photoshop (Adobe Systems). Digital prints were from a
Fujix Pictrography 3000 printer (Fuji).
 
Results
 
Tissue-specific Expression of Splice Variants
 
To investigate tissue-specific expression of the different
splice variants of D-AKAP1, Northern blots were probed
with 
 
32
 
P-labeled splice-specific cDNAs. As described pre-
viously, probing the blot with cDNA to the core region of
D-AKAP1 showed that the overall expression of the 3.8-kb
D-AKAP1 message is highest in heart, liver, skeletal mus-
cle, and kidney. In addition, a strong signal at 3.2-kb was
detected only in testis (Huang et al., 1997). Probing the
same blot with cDNA probes derived from unique regions
of the various splice variants allowed detection of splice-
specific expression (Fig. 2, b–d). Proteins containing the
Figure 1. Schematic dia-
gram of the various splices
and isoforms of D-AKAP1.
(a) Schematic diagram of
various mouse homologues
of D-AKAP1. All four iso-
forms share a 525–amino
acid core, including the
R-binding domain. A puta-
tive KH domain was identi-
fied in isoforms AKAP100
and D-AKAP1c (AKAP121).
This domain is shown as the
hatched box and the corre-
sponding sequences are un-
derlined. (b) The NH2 termi-
nal 30 and 63 residues are
shown for N0 and N1, re-
spectively. Residues RRCSY
represent the putative PKA
phosphorylation site identi-
fied in N1. 
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N1 splice were expressed exclusively in liver, while the C1
splice was expressed predominantly in testis. The C2 splice
had a more general expression pattern. Therefore, in addi-
tion to the distinct features revealed by amino acid se-
quences, these splice variants also were expressed in a
tissue-specific manner. Because the N0 splice contained
sequences shared by the core region, the expression pat-
tern specific for this NH
 
2
 
-terminal splice could not be ob-
tained. However, since the N1 splice was only expressed in
liver, the D-AKAP1s that are expressed in all the other
tissues most likely use the N0 splice.
 
Expression of [HA]-N0 and [HA]-N1
 
To determine the location of D-AKAP1 in cells, [HA]-N0
and [HA]-N1 that had an HA-tag at the NH
 
2 
 
terminus of
D-AKAP1a and D-AKAP1b were constructed as de-
scribed in the Materials and Methods. D-AKAP1a is com-
prised of the N0 splice and the C1 splice; D-AKAP1b is
comprised of the N1 splice and the C1 splice. To deter-
mine whether the vectors can express the appropriate pro-
teins, expression was tested first in a cell-free translation
system. As seen in Fig. 3, in vitro transcription-translation
of [HA]-N0 or [HA]-N1 gave protein products with the
apparent molecular mass of 107 and 114 kD, respectively.
These are approximately what would be predicted from
the sequence. To further verify these expressed products,
they were also subjected to immunoblot analysis using an-
tibodies raised against a core region of D-AKAP1 (RPP7)
or generated specifically to N1. Only the protein product
expressed from [HA]-N1 reacted with antibodies specific
for N1 (Fig. 3).
 
Residues 1–30 of the N0 Splice Variant Target
D-AKAP1 to Mitochondria
 
The NH
 
2
 
-terminal 30 amino acids of N0 has a putative mi-
tochondrial-targeting sequence in S-AKAP84 (Lin, 1995;
Chen et al., 1997). To further characterize the localiza-
tion of D-AKAP1 that used this N0 splice, the vector ex-
pressing D-AKAP1a with the HA tag at the NH
 
2
 
 termi-
nus was microinjected into 10T1/2 mouse fibroblasts.
Expressed proteins were visualized by immunofluores-
cence coupled with confocal microscopy. As seen in Fig. 4
A, cells expressing [HA]-N0 had a punctate immunofluo-
rescent staining concentrated around the nucleus, This
labeling was mimicked by a fluorescent mitochondrial
marker (Mitotracker), indicating its localization to the
mitochondria. To test if the HA-tag affected localization,
N0-[HA] was constructed. In this vector, the first 144
amino acids of D-AKAP1a were fused to a COOH-ter-
minal HA-tag. The staining pattern was identical for
both  [HA]-N0 and N0-[HA], and was thus independent of
epitope tags attached at either end (Fig. 4 B).
To confirm the mitochondrial localization in living cells
as well as in fixed cells, GFP was fused to the targeting se-
Figure 2. Splice variants of D-AKAP1 are expressed in a tissue-
specific manner. The same Northern blot containing immobilized
samples of mRNAs of selected adult tissues was probed with 32P-
radiolabeled cDNAs specific for the various splice variants: core
(A), N1 (B), C1 (C), and C2 (D). The size of the mRNA was indi-
cated on the right side of the blots. Panel a is taken from Huang
et al. (1997) with permission.
Figure 3. Cell-free expression of [HA]-N0 and [HA]-N1.
[35S]Methionine-labeled [HA]-N0 and [HA]-N1 were expressed
in an in vitro transcription-translation system and visualized by
autoradiography (A). These products were also subjected to im-
munoblot analysis using anti-RPP7 (B) or anti-N1 (C). 
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quence of cytochrome oxidase (Rizzuto et al., 1996). This
[GFP]-mitochondrial marker, [GFP]-mito, was used to
preclude the possibility of staining artifacts and confirm
localization to the mitochondria. Cells microinjected with
the expression vector for GFP alone had a diffuse distribu-
tion, filling the entire cell as previously reported (data not
shown; Pines, 1995). [GFP]-Mito, in contrast, displayed
typical mitochondria localization (Fig. 4 B).
To determine whether the first 30 residues of N0 are
necessary and/or sufficient to target mitochondria, two
additional constructs were engineered. [HA]-N0(
 
D
 
1
 
-
 
30)
contained HA-tagged full-length D-AKAP1a lacking the
first 30 residues, and (1-30)N0-[GFP] contained only the
first 30 residues of D-AKAP1a fused to GFP. As shown in
Fig. 4 C, when cDNA of [HA]-N0(
 
D
 
1
 
-
 
30) was microin-
jected into the nucleus of 10T1/2 cells, a diffused cyto-
plasmic staining pattern was observed indicating the loss
of mitochondrial targeting. In contrast, (1-30)N0-[GFP]
showed a characteristic mitochondrial pattern (Fig. 4 D).
Thus, as summarized in Fig. 4 E, the first 30 residues of N0
were not only necessary, but also sufficient for mitochon-
drial localization.
 
N1 Targets D-AKAP1b to ER
 
In addition to the N0 splice, D-AKAP1 has at least one al-
Figure 4. The N0 splice localizes to mitochondria. Confocal im-
ages of [HA]-N0 localization using anti-HA antibodies (red) co-
stained with a mitochondria fluorescent marker (A) or a mito-
chondrial targeted GFP marker (B) (both green). Yellow
staining indicates overlapped localization. Individual staining
patterns were shown in the insets. The blue staining shows immu-
nofluorescent detection of an IgG injection marker (A). [HA]-
N0(D1-30) shows a diffused cytoplasmic stain (C), while N0-
[GFP] exhibits a mitochondrial pattern (D). These results are
summarized schematically in E. The first 30 residues of N0 are
aligned with the first 15 residues of Hexokinase I. Identical resi-
dues are indicated in black boxes, and homologous residues are
indicated in gray boxes. 
The Journal of Cell Biology, Volume 145, 1999 956
 
ternative NH
 
2
 
-terminal splice variant, N1, that includes 33
extra amino acids NH
 
2
 
-terminal to the N0 splice. To in-
vestigate if these 33 residues affect the localization of
D-AKAP1, [HA]-N1 was constructed. [HA]-N1 encodes
HA-tagged D-AKAP1b, which consists of the N1 splice in
addition to D-AKAP1a. Cells microinjected with an ex-
pression construct for [HA]-N1 had a more “lacy” staining
pattern. Colocalization of [HA]-N1 with Bip, an hsp70 ho-
mologue that resides in the lumen of the ER (Haas, 1994),
indicated [HA]-N1 is targeted to the ER (Fig. 5 A). There-
fore, the extra 33 residues of the N1 splice not only abol-
ished mitochondrial targeting of D-AKAP1, but also ex-
hibited an ER-targeting function. Cells microinjected with
the [HA]-N1 expression vector were also cross-stained
 
with [GFP]-mito and showed no overlapping staining
(data not shown).
To further characterize this ER-targeting function of
N1, two deletion mutants, N1(
 
D
 
1-13) and N1(
 
D
 
1-24) were
engineered. N1(
 
D
 
1-13) contained the full-length D-AKAP1b
with the first 13 residues deleted, while N1(
 
D
 
1-24) con-
tained the full-length D-AKAP1b with the first 24 residues
deleted. Both had the HA tag fused to the NH
 
2
 
-terminus.
N1(
 
D
 
1-13), like full-length [HA]-D-AKAP1b, colocalized
with Bip, indicating its localization to the ER (Fig. 5 B),
whereas N1(
 
D
 
1-24) had a mixed localization pattern be-
tween ER and mitochondria. Fig. 5 C shows fluorescence
imaging of two cells microinjected with the N1(
 
D
 
1-24) ex-
pression construct that exhibited a more prominent mito-
Figure 5. The N1 splice localizes to endoplasmic reticulum. (A)
Confocal image of [HA]-N1 localization with anti-HA antibodies
(red) costained with anti-Bip antibodies (green). Yellow staining
indicates overlapped localization. Individual staining patterns
were shown in the insets. The blue staining shows immunofluo-
rescent detection of an IgG injection marker. (B) N1(D1-13)
(red) colocalizes with Bip (green). (C) N1(D1-24) (red) does not
colocalize with Bip (green). The results in A–C are summarized
schematically in D. In addition, mutagenesis studies of the puta-
tive PKA phosphorylation site (boxed residues) are also summa-
rized (data not shown). The dotted residues indicate the amino
acids used to replace the serine residue. 
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chondrial pattern. Since N1(
 
D
 
1-24) had decreased ability
to target D-AKAP1 to ER, residues 14–33 must partici-
pate in dictating the ER localization of N1.
Residues 14–33 of N1, as shown in Fig. 5 d, contain a po-
tential PKA phosphorylation site (RRCSY). To test if
phosphorylation of this site participated in the ER-target-
ing function of N1, three mutants with the potentially
phosphorylatable Ser changed to Ala, Glu, and Asp were
engineered in the construct [HA]-N1. All three mutants
exhibited ER localization (original data not shown).
 
The First 30 Residues of N0 Are Necessary for both 
Mitochondrial Targeting and ER Targeting
 
To further localize the ER-targeting signal, two GFP fu-
sion constructs were engineered. (1-63)N1-[GFP] contains
the 33 extra amino acids of N1 plus the 30 residues of
N0, sufficient for mitochondria targeting, fused to GFP.
(1-33)N1-[GFP] contains only the 33 residues of N1 fused
to GFP. As shown in Fig. 6 A, cells microinjected with the
expression vector encoding (1-63)N1-[GFP] had a lacy
staining pattern, characteristic of ER localization, whereas
 
cells microinjected with the (1-33)N1-[GFP] expression
vector showed a diffuse staining pattern, similar to GFP
alone (Fig. 6 B). Cells expressing (1-63)N1-[GFP] were
also stained with the anti-N1 antibody and ER localization
was detected (data not shown). These results indicated
that the 33 residues of N1, when fused to the mitochon-
drial-targeting sequence of N0, were sufficient to switch its
localization to the ER. However, these 33 amino acids
alone were not able to dictate ER localization. Therefore,
the ER-targeting signal is at least partially located within
the NH
 
2
 
-terminal 30 residues of N0. The 33 additional
amino acids at the NH
 
2
 
 terminus of N1 thus were able to
(a) suppress the mitochondrial-targeting function of N0
and (b) generate a new ER-targeting function. Since
HA-tagging at the NH
 
2
 
 terminus of N0 did not alter its mi-
tochondrial localization, it does not appear as though mi-
tochondrial targeting requires the insertion of the NH
 
2 
 
ter-
minal N0 motif into the membrane.
 
Discussion
 
Subcellular localization directed by specific targeting mo-
tifs is an emerging theme for regulating signal transduction
pathways. These targeting proteins recruit active enzymes
into signaling “modules” or place specific enzymes close to
their substrates. For example, proteins such as src are
brought to the plasma membrane by a myristylation motif
at its NH
 
2
 
 terminus. In addition, src homology 2 (SH2) do-
mains bind to specific phosphotyrosines, thus permitting
the assembly of signaling complexes in response to activa-
tion of cell surface receptors (Pawson et al., 1993; Waks-
man, 1994; Pawson and Scott, 1997). Similarly, subcellu-
lar compartmentalization of serine/threonine kinases and
phosphatases occurs through interactions with targeting
subunits or anchoring proteins that localize these enzymes
to specific sites (Hubbard and Cohen, 1993; Mochly-
Rosen, 1995; Klauck et al., 1996). AKAPs play major roles
in regulating the compartmentalization of PKA through
specific interactions with the NH
 
2
 
-terminal dimerization
domain of the R subunits (Pawson and Scott, 1997).
D-AKAP1 represents a family of AKAPs with splice
variants at both the NH
 
2
 
 terminus and COOH terminus.
We showed here that, based on Northern blot analysis,
three of these splice variants are expressed in a tissue-spe-
cific manner of the tissues tested. N1 was expressed exclu-
sively in liver, while C1 was expressed predominantly in
testis. C2 was expressed in all tissues tested but spleen,
consistent with the overall expression pattern of D-AKAP1
core. Furthermore, we demonstrated here that the two
NH
 
2
 
-terminal splice variants, N0 and N1, act as localization
switches to dictate subcellular localization of D-AKAP1 to
either mitochondria or endoplasmic reticulum. Fig. 7 sum-
marizes the functional properties of the motifs at the NH
 
2
 
terminus of N0 and N1.
The first 30 residues of D-AKAP1 were shown to be
necessary for mitochondrial targeting of mouse S-AKAP84
by cellular fractionation (Chen et al., 1997). Using micro-
injection of the various expression constructs coupled with
immunocytochemistry, we directly investigated the local-
ization of D-AKAP1. [HA]-N0 and N0-[HA] both exhib-
ited mitochondrial localization, whereas a construct lack-
ing the first 30 residues of N0 lost the targeting ability.
Figure 6. The N1 splice does not contain an ER-targeting signal.
Confocal images of 10T1/2 cells transfected with (1-63)N1-[GFP]
which displayed ER localization (A), and (1-33)N1-[GFP] with a
diffuse pattern (B). 
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These results confirmed that for D-AKAP1, the first 30
residues of N0 are necessary for proper targeting to mito-
chondria. Moreover, we took advantage of GFP-fusion
proteins that can be visualized without artificial staining
procedures in living cells. (1-30)N0-[GFP], which contains
only the first 30 residues of N0 fused to GFP, also exhib-
ited mitochondrial localization. Therefore, the first 30 resi-
dues of N0 are not only necessary but also sufficient to tar-
get D-AKAP1 to mitochondria.
When the first 30 amino acids of D-AKAP1 were com-
pared with another protein that localizes to the outer mi-
tochondrial membrane, hexokinase I, substantial similari-
ties were identified (Wilson, 1997; Xie and Wilson, 1988).
As shown in Fig. 4 E, in addition to the lack of negatively
charged residues, hydrophobic residues and consecutive
aromatic amino acids were homologous between the two
proteins. This conserved stretch of residues (residues 1–15
in hexokinase I) was also identified to be necessary and
sufficient to confer mitochondrial binding (Sui and Wil-
son, 1997). Recently, the crystal structure of the mamma-
lian hexokinase I was determined, revealing that this
stretch of mitochondrial-targeting residues forms an amphi-
pathic helix (Mulichak et al., 1998). Whether D-AKAP1
uses the same mechanism for mitochondrial targeting
awaits further investigation. However, since the attach-
ment of an epitope tag at the beginning of N0 did not abol-
ish targeting to mitochondria, it is unlikely that the NH
 
2
 
-
terminal motif simply inserts as an amphipathic helix into
the membrane bilayer as has been proposed for hexoki-
nase.
Surprisingly, despite the fact that N1 also contains the
stretch of hydrophobic residues necessary for mitochon-
drial targeting, it exhibited a dramatically different local-
ization. [HA]-N1 colocalized with Bip and showed a prom-
inent ER staining, indicating the localization to the ER.
Therefore, the extra 33 amino acids in N1, including a po-
tential myristylation site followed by a potential PKA
phosphorylation site, not only abolished mitochondrial
targeting of N0 but also generated an ER-targeting func-
tion. The two distinct localizations for the two NH
 
2
 
-termi-
nal splice variants of D-AKAP1 defines the first example
of an AKAP that shows a localization switch. Since N1 is
only expressed in the liver, this switch of mitochondrial
to ER localization may have physiological implications.
D-AKAP1 does not contain a conventional Lys-Asp-Glu-
Leu (KDEL) sequence that was shown to be essential for
ER retention of most soluble proteins (Andres et al.,
1990). Therefore, this ER localization of N1 might define a
novel mechanism for ER retention. Furthermore, with the
NH
 
2
 
-terminal HA-tagged N1 still localized to ER, myristy-
lation at the NH
 
2
 
 terminus of N1 is thus not likely to be
necessary for its ER targeting.
To further dissect N1, two deletion mutations were
constructed and examined. N1(
 
D
 
1-13) shows localization
to the ER, similar to the full-length [HA]-N1, whereas
N1(
 
D
 
1-24) has a mixed staining pattern at mitochondrial
and ER. Because N1(
 
D
 
1-33), i.e., [HA]-N0, localizes ex-
clusively to the mitochondria, residues 14-33 of N1 are es-
pecially important for the ER-targeting function. A poten-
tial PKA phosphorylation site was identified within this
region of N1. Nevertheless, three mutations with the po-
tentially phosphorylatable Ser changed to Ala, Asp, and
Glu all localized to ER. The Ser to Ala mutant localized to
ER, indicating that the unphosphorylated D-AKAP1 is
likely to reside in ER. Since Asp and Glu sometimes do
not fully mimic the phosphate moiety, whether phosphory-
lation affects targeting to ER is still unclear. However, the
ER localization is not altered in the presence of exogenous
cAMP analogue (data not shown), suggesting that phos-
phorylation may not be important for targeting.
By investigating the localization of (1-33)N1-[GFP],
(1-63)N1-[GFP], and (1-30)N0-[GFP], the localization
switch was further characterized. (1-33)N1-[GFP] showed
a diffuse pattern in the cytoplasm, similar to GFP, whereas
(1-63)N1-[GFP] localizes to ER. (1-30)N0-[GFP], i.e.,
(34-63)N1-[GFP], exhibited mitochondrial localization.
These results not only indicate that the extra 33 residues
do not contain an ER-targeting sequence, they also sug-
gest that at least part of the ER-targeting function is em-
bedded within the first 30 residues of N0 that also contain
the mitochondrial-targeting signal. Adding N1 to the NH
 
2
 
terminus of N0 somehow is able to suppress its mitochon-
drial-targeting ability and also to generate a new ER-tar-
geting signal. Whether this ER-targeting signal resides ex-
clusively in N0 and is only exposed upon addition of N1, or
whether this ER-targeting signal is instead generated by a
composite of N0 and a portion of N1 is still under investi-
gation.
The alternative splicing that alters the subcellular local-
ization of D-AKAP1 may represent a novel and important
regulatory mechanism to increase regulatory versatility
and allow for cell type–specific gene regulation for these
anchoring proteins and their signal transduction pathways.
Further effort to dissect the molecular mechanism for this
ER/mitochondria localization switch is underway.
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